Latest News about FDA
Recent news which mentions FDA
FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect
September 06, 2022
Tickers
EIGR
From Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
September 02, 2022
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
FDA Advisory Committee Meeting Scheduled For October 28, 2022 To Review Y-mAbs' Refiling For Omburtamab
September 01, 2022
Tickers
YMAB
From Benzinga
Intellia Gets FDA Orphan Drug Status For Hereditary Angioedema Candidate
September 01, 2022
Tickers
NTLA
From Benzinga
Amneal Seeks FDA Approval For Its Parkinson's Candidate
September 01, 2022
Tickers
AMRX
From Benzinga
From Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
September 01, 2022
Tickers
SNY
From Benzinga
From Benzinga
From Benzinga
Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
August 31, 2022
Tickers
LGVN
From Benzinga
Outlook Therapeutics Shares Pop After Filing US Application For Its Lead Eye Disease Candidate
August 30, 2022
Tickers
OTLK
From Benzinga
Curis Resumes Enrollment In Monotherapy TakeAim Leukemia Study, Combo Phase Still Under Partial Hold
August 30, 2022
Tickers
CRIS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.